The size of the medical devices market in the Middle East and Africa is estimated to grow USD 34.75 billion by 2029 from USD 27.35 billion in 2024, growing at a CAGR of 4.9% from 2024 to 2029.
Advances in medical devices such as ECG, blood pressure monitors, blood dialyzers, pacemakers, ventilators, and others increase the effectiveness of treatment, which benefits many patients in the long term. Furthermore, the emergence of 3D technology for the treatment of various therapies fuels the growth of the medical devices market in the MEA region. In addition, government initiatives to reimburse the use of healthcare facilities and the use of medical devices by creating awareness are influencing the growth of the market.
Access to healthcare facilities is considered a fundamental right in Saudi Arabia, which is one of the main reasons for the increasing demand for the use of medications in the Middle East. Since the prevalence of chronic conditions such as kidney stones and diabetes increases, the need for accessories such as catheters and guides, which are a crucial part of treatment, is also estimated to increase, stimulating the growth of the market. The launch of new products with improved device performance using real-time features and remote monitoring is catalyzing the development of the medical device market. Additionally, there is high demand for personal, portable, and biocompatible devices owing to growing awareness.
The growing consumer preference for adopting their own and at-home treatments is increasing at a rapid rate. Furthermore, in the past several years, there have been technological advancements in medical devices, such as the adoption of glucose monitoring devices, insulin delivery devices, pumps, and oxygen concentrators, which have led to the adoption of diagnostics and treatments in the comfort of home. As a result, the entry of several new players and the collaborative efforts of existing players are estimated to increase during the forecast period.
However, the MEA medical devices market is estimated to be restrained by poor health care infrastructure and low reimbursements plans. Other factors that might hamper the market growth in the future include challenges due to regulatory changes, price margins, data security concerns, and product recalls.
This research report on the Middle East and Africa medical devices market has been segmented and sub-segmented into the following categories:
By Type:
By End-User:
By Country:
Geographically, over the anticipated period, regional markets in Qatar, United Arab Emirates, and Iraq are anticipated to foster the fastest growth for the MEA region. While, exports and distribution of medical devices will benefit from accelerating economic growth in sub-Saharan Africa, supported by rising commodity prices and growing investors in the region. However, the region remains highly vulnerable to political conflicts.
South Africa is the main trading center for the medical device industry in sub-Saharan Africa. As a result, a substantial portion of medical devices and laboratory equipment in the African region are shipped to other parts of Africa. In addition, the prevalence of certain conditions, such as kidney stones, increases with age, according to Investigative and Clinical Urology publication, 2017. As a result, as the population of the region increases, the prevalence of kidney stones is projected to increase, which is expected to accelerate the market for portable medical devices in this country.
Key manufacturers are increasingly focusing on the research and development process to drive the regional market growth in the Middle East. Medical devices are growing in popularity with the widespread distribution of advanced devices in regions such as Saudi Arabia, Kuwait, Qatar, and Egypt.
KEY MARKET PLAYERS:
Companies playing a significant role in the MEA medical devices market profiled in this report are Medtronic, Stryker, Fresenius SE & Co. KGaA, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd, General Electric Company, Siemens Healthineers AG, BD, Boston Scientific Corporation, and Johnson & Johnson Services, Inc.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region